DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Intersect ENT 

(formerly Sinexus)
1049 Elwell Court
Palo Alto  California  94303  U.S.A.
Phone: 650-641-2100 Fax: n/a


SEARCH JOBS










 Company News
Intersect ENT Announces Positive Results From Pilot Study of Novel In-Office Implant for Chronic Sinusitis Patients 9/30/2013 10:59:17 AM    More...
Intersect ENT Announces Positive Results From Pilot Study of Novel in-Office Implant for Chronic Sinusitis Patients 9/30/2013 7:46:43 AM    More...
Intersect ENT Grabs $30 Million for Drug/Device Combo for the Sinuses 2/25/2013 7:51:18 AM    More...
Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients 1/31/2013 10:17:01 AM    More...
Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant 11/6/2012 6:56:22 AM    More...
Intersect ENT Release: Groundbreaking Clinical Evidence Demonstrates Benefit of PROPEL Implant for Chronic Sinusitis Patients 6/6/2012 12:26:53 PM    More...
Intersect ENT Quadruples Operation Size With Move to Menlo Park 4/18/2012 9:04:16 AM    More...
Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes for Sinus Surgery 9/14/2011 6:50:15 AM    More...
Intersect ENT Announces U.S. FDA Approval for First Drug Releasing Implant for Chronic Sinusitis Patients 8/15/2011 6:34:45 AM    More...
Intersect ENT Closes $30M Series C Financing, Recognized for Clinical Science 11/1/2010 7:22:35 AM    More...
12